Before Wegovys launch, the number of providers with at least one written GLP-1 prescription remained relatively stable
Talk to a doctor
Looking ahead, the future of PDCs involves the development of PDCs based on humanized antibodies, 129 exploring stimuli-responsive drug release mechanisms, 130 employing computer-aided drug design, 131 exploring diverse receptors or antigens, 132 integrating with immunotherapies and gene therapies to address stability, off-target effects and resistance issues, 133,134 and advancing scalable manufacturing processes
Early time-restricted feeding improves 24-hour glucose levels and affects markers of the circadian clock, aging, and autophagy in humans
I think hes directionally correct, but overshot how severe the threat really is